Pharmabiz4h
Signet begins patient dosing in phase I trial in China for SIGX1094 to treat diffuse gastric cancer and other advanced solid tumours
Signet begins patient dosing in phase I trial in China for SIGX1094 to treat diffuse gastric cancer and other advanced solid tumours: New York Thursday, January 16, 2025, 14:00 Hr ...
Pharmabiz6h
GenSight Biologics announces publication of 5-year outcomes for patients treated unilaterally with Lumevoq gene therapy
GenSight Biologics announces publication of 5-year outcomes for patients treated unilaterally with Lumevoq gene therapy: Paris, France Thursday, January 16, 2025, 18:00 Hrs [IST] ...
Pharmabiz7h
Annovis Bio’s buntanetap receives US patent for treatment and prevention of acute brain or nerve injuries
Annovis Bio’s buntanetap receives US patent for treatment and prevention of acute brain or nerve injuries: Malvern, Pennsylvania Thursday, January 16, 2025, 17:00 Hrs [IST] Anno ...
Pharmabiz8h
Vistagen reports positive results from exploratory phase 2A study of PH284 in cancer cachexia
Vistagen reports positive results from exploratory phase 2A study of PH284 in cancer cachexia: South San Francisco, California Thursday, January 16, 2025, 16:00 Hrs [IST] Vistagen ...
Pharmabiz9h
icotec gets US FDA 510(k) clearance for use of BlackArmor implants to treat de novo spinal infections
FDA clearance for the use of BlackArmor implants in the treatment of de novo spinal infections. icotec is honoured to be the first and only company in the United States with FDA 510(k) clearance for ...
Pharmabiz10h
Glaukos announces positive clinical updates for its iDose sustained-release procedural pharmaceutical platform
Glaukos announces positive clinical updates for its iDose sustained-release procedural pharmaceutical platform: Aliso Viejo, California Thursday, January 16, 2025, 14:30 Hrs [IST] ...
Pharmabiz10h
ACT commits Rs. 8.33 crore to the future of rural healthcare in India with Khushi Baby & Medoplus
ACT commits Rs. 8.33 crore to the future of rural healthcare in India with Khushi Baby & Medoplus: Our Bureau, Bengaluru Thursday, January 16, 2025, 14:15 Hrs [IST] ACT, an Indian ...
Pharmabiz11h
Acadia Pharma seeks European marketing approval for trofinetide for the treatment of Rett syndrome
Acadia Pharma seeks European marketing approval for trofinetide for the treatment of Rett syndrome: San Diego Thursday, January 16, 2025, 13:00 Hrs [IST] Acadia Pharmaceuticals In ...
Pharmabiz12h
Pasithea Therapeutics opens European clinical trial sites and completes initial dosing of cohort 4
Pasithea Therapeutics opens European clinical trial sites and completes initial dosing of cohort 4: Miami Thursday, January 16, 2025, 12:00 Hrs [IST] Pasithea Therapeutics Corp., ...
Pharmabiz13h
Olfactive Biosolutions granted third dual GLP-1/GIP patent in US to repurpose food molecules for weight management and blood sugar regulation
Mountain View, California Thursday, January 16, 2025, 11:00 Hrs [IST] ...
Pharmabiz15h
Health Canada approves MedMira’s Reveal G4 Rapid HIV-1/2 test for point-of-care use
Health Canada approves MedMira’s Reveal G4 Rapid HIV-1/2 test for point-of-care use: Halifax, Nova Scotia Thursday, January 16, 2025, 09:00 Hrs [IST] MedMira Inc. (MedMira) anno ...
Pharmabiz16h
With home health monitoring devices, India can improve public health: Tetsuya Yamada
With home health monitoring devices, India can improve public health: Tetsuya Yamada: Nandita Vijayasimha, Bengaluru Thursday, January 16, 2025, 08:00 Hrs [IST] India can establis ...